HORIZON program provides recommendations for psoriasis patients with specific joint involvement. Dr. Wayne Gulliver, Chair and Medical Director of NewLab Clinical Research in St, John’s, speaks about the efficacy of IL-17 inhibitors and TNFs for treatment of psoriatic arthritis.
HealthMinute.TV 